Timothy A Marlowe
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2019First federal award
$5.9MFederal grants as PI10 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
10 awards · $5.9M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 4, 2026 | NIH | STTR Phase II Non-catalytic FAK inhibitors as novel therapeutics for lung fibrosis | $663K | Faknostics, LLC |
| Aug 3, 2026 | NIH | STTR Phase II Novel Paxillin-FAK Inhibitors for the Treatment of Liver Fibrosis | $669K | Faknostics, LLC |
| Aug 26, 2025 | NIH | STTR Phase II Non-catalytic FAK inhibitors as novel therapeutics for lung fibrosis | $663K | Faknostics, LLC |
| Aug 7, 2025 | NIH | STTR Phase II Novel Paxillin-FAK Inhibitors for the Treatment of Liver Fibrosis | $664K | Faknostics, LLC |
| Sep 6, 2024 | NIH | STTR Phase II Novel Paxillin-FAK Inhibitors for the Treatment of Liver Fibrosis | $326K | Faknostics, LLC |
| Aug 30, 2024 | NIH | STTR Phase II Non-catalytic FAK inhibitors as novel therapeutics for lung fibrosis | $674K | Faknostics, LLC |
| Aug 2, 2023 | NIH | STTR Phase II Development of Non-Catalytic Peptide Inhibitors of Focal Adhesion Kinase (FAK) for Use in Melanoma | $655K | Faknostics, LLC |
| Jul 22, 2022 | NIH | STTR Phase II Development of Non-Catalytic Peptide Inhibitors of Focal Adhesion Kinase (FAK) for Use in Melanoma | $671K | Faknostics, LLC |
| Aug 12, 2021 | NIH | STTR Phase II Development of Non-Catalytic Peptide Inhibitors of Focal Adhesion Kinase (FAK) for Use in Melanoma | $675K | Faknostics, LLC |
| Aug 30, 2019 | NIH | STTR Phase I Discovery of Novel Peptidic Inhibitors of the Non-Catalytic Function of Focal Adhesion Kinase (FAK) | $290K | Faknostics, LLC |
Peer ranks
Federal funding#193
Awards as PI#128
Patents#273
Companies
- Faknostics, LLCLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.